CBER Proposes Increasing Cell, Gene Therapy Staff In PDUFA VII

'Indirect and direct review roles' would be added with user fee funds after the PDUFA program is reauthorized.

A businessman in blue shirt is holding a magnifying glass in his hand, is searching for personnel or people. Detective looking for missing person crowd of miniature figures choosing most suitable one - Image
CBER wants to add and on-board the new staff as soon as feasible during PDUFA VII. • Source: Shutterstock

US Food and Drug Administration officials want user fees to fund more staff for the cell and gene therapy program.

The Center for Biologics Evaluation and Research wants additional support staff, as well as “indirect and direct review roles.” An...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Cell & Gene Therapies

More from Advanced Technologies